Patents by Inventor Rongjuan Lu

Rongjuan Lu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bimacrocylic HCV NS3 protease inhibitors
    Patent number: 8703700
    Abstract: Inhibitors of the hepatitis C virus (HCV) NS3 protease are provided. In particular, bimacrocyclic compounds and their pharmaceutical compositions for the treatment of HCV infections are provided. Methods of making the bimacrocyclic compounds and their pharmaceutical compositions, and methods of using the compounds for treating HCV infections are also provided.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: April 22, 2014
    Assignee: Sequoia Pharmaceuticals, Inc.
    Inventors: Pavel Majer, Michael Eissenstat, Rongjuan Lu
  • Bimacrocylic HCV NS3 Protease Inhibitors
    Publication number: 20120141414
    Abstract: Inhibitors of the hepatitis C virus (HCV) NS3 protease are provided. In particular, bimacrocyclic compounds and their pharmaceutical compositions for the treatment of HCV infections are provided. Methods of making the bimacrocyclic compounds and their pharmaceutical compositions, and methods of using the compounds for treating HCV infections are also provided.
    Type: Application
    Filed: May 24, 2010
    Publication date: June 7, 2012
    Applicant: Sequoia Pharmaceuticals, Inc.
    Inventors: Pavel Majer, Michael Eissenstat, Rongjuan Lu